Liverpool ChiroChem, which is part of both the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS portfolios, has announced a new partnership with Molecular Forecaster, which is a leading scientific software and consulting company.
Both companies have announced a pilot project collaboration to discover novel asymmetric small-molecule catalysts for the synthesis of enantiopure drug candidates.
Read more about the partnership, here.
About Liverpool ChiroChem
Liverpool ChrioChem are specialists in chemical building blocks & chiral small molecules. They have developed an innovative production process to manufacture its own proprietary chemical compounds for sale, and therefore is able to provide researchers with small volumes of high value chemicals that are currently of high interest but frequently beyond financial reach of resource-constrained research programmes.